| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | intracellularly cAMP-activated cation channel activity | 4.72e-05 | 10 | 21 | 2 | GO:0005222 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 5.76e-05 | 11 | 21 | 2 | GO:0098973 | |
| GeneOntologyMolecularFunction | intracellularly cyclic nucleotide-activated monoatomic cation channel activity | 8.16e-05 | 13 | 21 | 2 | GO:0005221 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-activated monoatomic ion channel activity | 8.16e-05 | 13 | 21 | 2 | GO:0043855 | |
| GeneOntologyMolecularFunction | cAMP binding | 3.11e-04 | 25 | 21 | 2 | GO:0030552 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 3.37e-04 | 26 | 21 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 4.02e-04 | 627 | 21 | 5 | GO:0022890 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 5.13e-04 | 32 | 21 | 2 | GO:0099186 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 5.20e-04 | 152 | 21 | 3 | GO:0022843 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 5.23e-04 | 664 | 21 | 5 | GO:0008324 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 5.45e-04 | 33 | 21 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 7.33e-04 | 171 | 21 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | cyclic nucleotide binding | 7.62e-04 | 39 | 21 | 2 | GO:0030551 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 8.78e-04 | 182 | 21 | 3 | GO:0005244 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 8.84e-04 | 42 | 21 | 2 | GO:0098918 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 9.06e-04 | 184 | 21 | 3 | GO:0022832 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 9.53e-04 | 758 | 21 | 5 | GO:0015318 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 1.17e-03 | 793 | 21 | 5 | GO:0015075 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.27e-03 | 465 | 21 | 4 | GO:0046873 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.35e-03 | 52 | 21 | 2 | GO:0005272 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.93e-03 | 334 | 21 | 3 | GO:0022836 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 5.09e-03 | 102 | 21 | 2 | GO:0005249 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 5.31e-03 | 343 | 21 | 3 | GO:0005261 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 6.00e-03 | 111 | 21 | 2 | GO:0003727 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 6.57e-03 | 1180 | 21 | 5 | GO:0022857 | |
| GeneOntologyMolecularFunction | potassium channel activity | 7.91e-03 | 128 | 21 | 2 | GO:0005267 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 8.15e-03 | 130 | 21 | 2 | GO:0005200 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 9.39e-03 | 140 | 21 | 2 | GO:0099094 | |
| GeneOntologyMolecularFunction | transporter activity | 9.49e-03 | 1289 | 21 | 5 | GO:0005215 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.18e-02 | 459 | 21 | 3 | GO:0005216 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 1.32e-02 | 167 | 21 | 2 | GO:0015079 | |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 2.31e-05 | 61 | 19 | 3 | GO:0003254 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 1.78e-04 | 121 | 19 | 3 | GO:0051899 | |
| GeneOntologyBiologicalProcess | membrane depolarization during cardiac muscle cell action potential | 2.01e-04 | 23 | 19 | 2 | GO:0086012 | |
| GeneOntologyCellularComponent | HCN channel complex | 5.76e-06 | 4 | 21 | 2 | GO:0098855 | |
| GeneOntologyCellularComponent | axon | 1.72e-05 | 891 | 21 | 7 | GO:0030424 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 4.68e-04 | 32 | 21 | 2 | GO:0043189 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 4.68e-04 | 32 | 21 | 2 | GO:0035267 | |
| GeneOntologyCellularComponent | supramolecular fiber | 8.28e-04 | 1179 | 21 | 6 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 8.58e-04 | 1187 | 21 | 6 | GO:0099081 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 9.27e-04 | 45 | 21 | 2 | GO:1902562 | |
| GeneOntologyCellularComponent | cation channel complex | 1.61e-03 | 235 | 21 | 3 | GO:0034703 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 1.65e-03 | 523 | 21 | 4 | GO:1902495 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 1.66e-03 | 899 | 21 | 5 | GO:0099513 | |
| GeneOntologyCellularComponent | transporter complex | 1.99e-03 | 550 | 21 | 4 | GO:1990351 | |
| GeneOntologyCellularComponent | dendritic shaft | 2.49e-03 | 74 | 21 | 2 | GO:0043198 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 3.73e-03 | 91 | 21 | 2 | GO:0008076 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 3.97e-03 | 94 | 21 | 2 | GO:0000123 | |
| GeneOntologyCellularComponent | potassium channel complex | 4.84e-03 | 104 | 21 | 2 | GO:0034705 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 4.84e-03 | 104 | 21 | 2 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 5.30e-03 | 109 | 21 | 2 | GO:1902493 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 6.13e-03 | 378 | 21 | 3 | GO:0034702 | |
| MousePheno | abnormal depression-related behavior | 9.87e-06 | 156 | 13 | 4 | MP:0003360 | |
| MousePheno | abnormal impulse conducting system conduction | 1.99e-05 | 400 | 13 | 5 | MP:0003137 | |
| MousePheno | stereotypic behavior | 3.43e-05 | 214 | 13 | 4 | MP:0001408 | |
| MousePheno | postnatal lethality | 2.29e-04 | 1084 | 13 | 6 | MP:0002082 | |
| MousePheno | abnormal heart electrocardiography waveform feature | 3.07e-04 | 377 | 13 | 4 | MP:0010508 | |
| MousePheno | impaired olfaction | 3.20e-04 | 29 | 13 | 2 | MP:0008544 | |
| Domain | Ion_trans_N | 6.53e-06 | 4 | 20 | 2 | PF08412 | |
| Domain | Ion_trans_N | 6.53e-06 | 4 | 20 | 2 | IPR013621 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 9.84e-05 | 14 | 20 | 2 | IPR003938 | |
| Domain | Actin_CS | 1.30e-04 | 16 | 20 | 2 | IPR004001 | |
| Domain | ACTINS_2 | 1.47e-04 | 17 | 20 | 2 | PS00432 | |
| Domain | Actin/actin-like_CS | 1.65e-04 | 18 | 20 | 2 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 1.84e-04 | 19 | 20 | 2 | PS01132 | |
| Domain | Ion_trans_dom | 2.34e-04 | 114 | 20 | 3 | IPR005821 | |
| Domain | Ion_trans | 2.34e-04 | 114 | 20 | 3 | PF00520 | |
| Domain | ACTIN | 4.97e-04 | 31 | 20 | 2 | SM00268 | |
| Domain | Actin | 4.97e-04 | 31 | 20 | 2 | IPR004000 | |
| Domain | Actin | 4.97e-04 | 31 | 20 | 2 | PF00022 | |
| Domain | CNMP_BINDING_1 | 5.30e-04 | 32 | 20 | 2 | PS00888 | |
| Domain | CNMP_BINDING_2 | 5.30e-04 | 32 | 20 | 2 | PS00889 | |
| Domain | cNMP | 5.99e-04 | 34 | 20 | 2 | SM00100 | |
| Domain | cNMP_binding | 5.99e-04 | 34 | 20 | 2 | PF00027 | |
| Domain | cNMP-bd_dom | 6.35e-04 | 35 | 20 | 2 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 6.35e-04 | 35 | 20 | 2 | PS50042 | |
| Domain | cNMP-bd-like | 7.48e-04 | 38 | 20 | 2 | IPR018490 | |
| Domain | - | 1.19e-03 | 48 | 20 | 2 | 2.60.120.10 | |
| Domain | RmlC-like_jellyroll | 1.35e-03 | 51 | 20 | 2 | IPR014710 | |
| Domain | Ank_2 | 2.19e-02 | 215 | 20 | 2 | PF12796 | |
| Domain | Ank | 2.44e-02 | 228 | 20 | 2 | PF00023 | |
| Pubmed | Pacsin 2 is required for the maintenance of a normal cardiac function in the developing mouse heart. | 6.88e-08 | 14 | 21 | 3 | 29107716 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 18033814 | ||
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 3.47e-07 | 2 | 21 | 2 | 19669888 | |
| Pubmed | HCN3 ion channels: roles in sensory neuronal excitability and pain. | 3.47e-07 | 2 | 21 | 2 | 31290157 | |
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 1.04e-06 | 3 | 21 | 2 | 17101985 | |
| Pubmed | A family of hyperpolarization-activated mammalian cation channels. | 1.04e-06 | 3 | 21 | 2 | 9634236 | |
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 16043489 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 25042871 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 22748890 | ||
| Pubmed | Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons. | 2.08e-06 | 4 | 21 | 2 | 26966193 | |
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 21615589 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 20140458 | ||
| Pubmed | Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain. | 2.08e-06 | 4 | 21 | 2 | 9630217 | |
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 9405696 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 12928435 | ||
| Pubmed | 3.47e-06 | 5 | 21 | 2 | 34429357 | ||
| Pubmed | Functional coupling of Tmem74 and HCN1 channels regulates anxiety-like behavior in BLA neurons. | 3.47e-06 | 5 | 21 | 2 | 30886335 | |
| Pubmed | Regulation of HCN channel surface expression by a novel C-terminal protein-protein interaction. | 3.47e-06 | 5 | 21 | 2 | 15564593 | |
| Pubmed | Transcription profiling of HCN-channel isotypes throughout mouse cardiac development. | 7.28e-06 | 7 | 21 | 2 | 19421833 | |
| Pubmed | 7.28e-06 | 7 | 21 | 2 | 27956497 | ||
| Pubmed | 1.56e-05 | 10 | 21 | 2 | 16382102 | ||
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 3.63e-05 | 15 | 21 | 2 | 16824795 | |
| Pubmed | 5.10e-05 | 347 | 21 | 4 | 17114649 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 7.88e-05 | 139 | 21 | 3 | 16985003 | |
| Pubmed | 1.60e-04 | 31 | 21 | 2 | 37816598 | ||
| Interaction | IL25 interactions | 5.91e-08 | 44 | 18 | 4 | int:IL25 | |
| Interaction | ACTG2 interactions | 1.07e-05 | 49 | 18 | 3 | int:ACTG2 | |
| Interaction | CCDC177 interactions | 1.13e-05 | 6 | 18 | 2 | int:CCDC177 | |
| Interaction | KCNE2 interactions | 2.10e-05 | 8 | 18 | 2 | int:KCNE2 | |
| Interaction | HCN4 interactions | 2.70e-05 | 9 | 18 | 2 | int:HCN4 | |
| Interaction | CXorf38 interactions | 3.38e-05 | 10 | 18 | 2 | int:CXorf38 | |
| Interaction | ERRFI1 interactions | 1.12e-04 | 107 | 18 | 3 | int:ERRFI1 | |
| Interaction | OARD1 interactions | 1.14e-04 | 18 | 18 | 2 | int:OARD1 | |
| Interaction | CPA5 interactions | 1.72e-04 | 22 | 18 | 2 | int:CPA5 | |
| Interaction | INSL6 interactions | 2.23e-04 | 25 | 18 | 2 | int:INSL6 | |
| Cytoband | 2q21.1 | 3.24e-04 | 58 | 21 | 2 | 2q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q21 | 2.17e-03 | 151 | 21 | 2 | chr2q21 | |
| GeneFamily | Cyclic nucleotide gated channels | 2.88e-05 | 10 | 15 | 2 | 250 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 4.98e-05 | 13 | 15 | 2 | 685 | |
| GeneFamily | Ankyrin repeat domain containing | 1.67e-02 | 242 | 15 | 2 | 403 | |
| GeneFamily | WD repeat domain containing | 1.94e-02 | 262 | 15 | 2 | 362 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.97e-06 | 196 | 21 | 4 | b71d711be5609115b00a57700885aca608920896 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-05 | 136 | 21 | 3 | 7cd22169fb71c6caf9feb203ad98be8480a54fba | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.81e-05 | 162 | 21 | 3 | 388670cf3acef17df971c0d8ae3ce14398945192 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.81e-05 | 162 | 21 | 3 | 9333d923225df7bfdf6b3a4c32816751315aec50 | |
| ToppCell | Mild-Myeloid-Mast-|Mild / Condition, Lineage, Cell class and cell subclass | 6.14e-05 | 165 | 21 | 3 | 93d3909a0f5f43d473d5005c842d7d73e25eceed | |
| ToppCell | Mild-Myeloid-Mast|Mild / Condition, Lineage, Cell class and cell subclass | 6.14e-05 | 165 | 21 | 3 | 5fa9552c37890c5cc7e672a47038aebba2413cb4 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-05 | 170 | 21 | 3 | d99f61aa85ea3f775165cb433421e6f1cda4f96b | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-05 | 170 | 21 | 3 | 615cf9639c66b3fbd984ebe3f345280005d3c38a | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-05 | 178 | 21 | 3 | a3176b2b335db22bb0fb71aafa5d7a287809396e | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.34e-05 | 183 | 21 | 3 | 9e6c96ada930e8559246a270dfc69fb3cbb3bdf3 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.89e-05 | 187 | 21 | 3 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.03e-05 | 188 | 21 | 3 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | distal-3-Hematologic-Basophil/Mast_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.76e-05 | 193 | 21 | 3 | 23c6c798525dad43eff792727902ea562bf373be | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 195 | 21 | 3 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-04 | 197 | 21 | 3 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | distal-1-mesenchymal-Pericyte|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.08e-04 | 200 | 21 | 3 | ff205afda57b9267016f0c937445da1b0266af9b | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-04 | 200 | 21 | 3 | 78cd0b7d221ef855512ee9ac9a291f61622c2e24 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.98e-04 | 63 | 21 | 2 | d7dc1356a60cb527fe668328d5375f352239d911 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.24e-04 | 65 | 21 | 2 | 3592efe68696dd5b806183c8bcd4957c1cd8e045 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.24e-04 | 65 | 21 | 2 | c53b6e1e454b7c34cac07b287ffd9e8e64fa79c8 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.07e-04 | 84 | 21 | 2 | 5d5e519a6652029b9f5275c8e648bbb123fd07b9 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.07e-04 | 84 | 21 | 2 | f7ce09c6fb2795b7aecabce00cb9830b3c1a7d0e | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.07e-04 | 84 | 21 | 2 | 2b477de422a9f6a8474cba05094577b88236a4f0 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-9|TCGA-Breast / Sample_Type by Project: Shred V9 | 8.11e-04 | 90 | 21 | 2 | 96e836c7a1df279ac812b7c3aa75e6b81b614244 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Malignant_Peripheral_Nerve_Sheath_Tumors-3|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.14e-03 | 107 | 21 | 2 | c6c6ace2e578e48f135b53e50ece540350dc640a | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-03 | 107 | 21 | 2 | 5bae4b3aede9bcbf7e88414e3453973cc8b0c3e7 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-03 | 107 | 21 | 2 | 410b37beffaf637a2a64c9d0ce7baf81f4bc667c | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B1|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-03 | 111 | 21 | 2 | 9972d31966b059aa3446407b73b714b0b06ec815 | |
| ToppCell | Control-CD4+_T_activated|Control / Disease condition and Cell class | 1.34e-03 | 116 | 21 | 2 | e3d1a90a229f5697b2b715574bb96790a435f73b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.39e-03 | 118 | 21 | 2 | f76fc6db7368a1e8e5e4f8535fc3dc78afe13b9b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.39e-03 | 118 | 21 | 2 | 0dcac16eea8e7978de370a815da9a0cdd212598e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.39e-03 | 118 | 21 | 2 | 7da3957d102e9f9825fc2609d6d0bd9ca6a3fba4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.39e-03 | 118 | 21 | 2 | c5c6724e0e526d7c2fc8cabff4a112a900ec997f | |
| ToppCell | Control-Lymphoid_T/NK-CD4+_T_activated|Control / Disease group, lineage and cell class | 1.41e-03 | 119 | 21 | 2 | d7352d0dafbb664619b7a1e3cd07b159fdfec197 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.55e-03 | 125 | 21 | 2 | 5626eb77e542fcc87cd1fdf65f8623f3249ff9db | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Interneuron|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.58e-03 | 126 | 21 | 2 | ec445ec097c9c45cd47b8cfa8c140df5b298695e | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-03 | 126 | 21 | 2 | 10e1448a03f79965b72922fd83ef51de1b7b474f | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-03 | 134 | 21 | 2 | 0e3f37ef041b751ed45060b5ce39385a2731370b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-03 | 135 | 21 | 2 | 88f86bab637f1ca1439c7de2d12be4329cf662b8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-03 | 140 | 21 | 2 | 5e81fa3a19d23f0e9cae3878431ca1f78dff7238 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.94e-03 | 140 | 21 | 2 | af9efcbaeeae69fcdac4a15fa244728b65915564 | |
| ToppCell | Healthy-CD4+_T_activated|World / disease group, cell group and cell class | 1.94e-03 | 140 | 21 | 2 | 407691970ec72a3afb45e431cf48814546b8acff | |
| ToppCell | COVID-19-Mast_cells-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 1.97e-03 | 141 | 21 | 2 | 0fc06c2325249aa4ae65c0ace1ec3f953372f2e4 | |
| ToppCell | critical-Lymphoid-NKT|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.02e-03 | 143 | 21 | 2 | dca035bfbfd1665c04076c43da8bc18a1502b9de | |
| ToppCell | Healthy-CD4+_T_activated|Healthy / disease group, cell group and cell class | 2.08e-03 | 145 | 21 | 2 | 45e8089fdf7d6f69b383816d8945e39fba24c873 | |
| ToppCell | COVID-19_Moderate-multiplets|COVID-19_Moderate / disease group, cell group and cell class | 2.14e-03 | 147 | 21 | 2 | baf15c773d7751bc6f64d4974a22738626f2b3ff | |
| ToppCell | Ciliated_cells-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.25e-03 | 151 | 21 | 2 | 9d03ce73af15ef40c592d19b36aff46bebc14c40 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-03 | 151 | 21 | 2 | f5ae450e3daa10540ca8437d05efe2d86ac70960 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-03 | 152 | 21 | 2 | 9391b46a441cf031665df1d142e3f65e98675eeb | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.31e-03 | 153 | 21 | 2 | d3fb83ca984c7583b1e51c364be6c7c17f67b048 | |
| ToppCell | Adult-Immune-dendritic_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.34e-03 | 154 | 21 | 2 | 64a4686586d08b1e9632dde917b472ac660de2d3 | |
| ToppCell | Adult-Immune-mast_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.37e-03 | 155 | 21 | 2 | 7c9de0591d1bf756b8e268b278bbe10bd5415dcd | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 2.40e-03 | 156 | 21 | 2 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.40e-03 | 156 | 21 | 2 | ffb9249a115ce31f50b99a7a3d40bf48b9d7f2b0 | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 2.40e-03 | 156 | 21 | 2 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.40e-03 | 156 | 21 | 2 | c380142e49b1e4ecacbf37587aafa57f8562b6ad | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.40e-03 | 156 | 21 | 2 | a5930b455e5c8586c43c50106ab4d8a1e5e9e3d6 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-03 | 158 | 21 | 2 | 91d265e95156f16459924d3e4dd11c180e164eee | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.46e-03 | 158 | 21 | 2 | 944c5fe625f965dd6153dbcbf5577f99ad343983 | |
| ToppCell | 10x5'-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue | 2.49e-03 | 159 | 21 | 2 | c3d3570e83c5d25cc92fa3a7a8f0dc2f89a72913 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Mast|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-03 | 160 | 21 | 2 | 6393e3d5c5c8176c93aecd89b313bd054a00d474 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-03 | 160 | 21 | 2 | 9f1fec2cf565193c73cc3c8a4f0476e57478e3b8 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.52e-03 | 160 | 21 | 2 | 8374ae912337947b2cc8d17d5840f306361fe1ff | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-03 | 160 | 21 | 2 | 2065938e944eb99478fd8132c2c03adeaee6d447 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.56e-03 | 161 | 21 | 2 | 0e2b54a63781397f6b99eb0e201fbb820cbd7cc6 | |
| ToppCell | Adult-Immune-mast_cell|Adult / Lineage, Cell type, age group and donor | 2.56e-03 | 161 | 21 | 2 | 44f5c0256b3ce264a6c7b62740f32dcd45ee052d | |
| ToppCell | 10x5'-bone_marrow-Mast-Mast_cells|bone_marrow / Manually curated celltypes from each tissue | 2.56e-03 | 161 | 21 | 2 | 15ba7e69699558353cfeecdcf1dbc2e147379ed6 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.56e-03 | 161 | 21 | 2 | f50e91f8363f20bb7c565aaca4d4961d3fe4b5b5 | |
| ToppCell | Control-Lymphocyte-B-Plasmablast|Control / Disease, Lineage and Cell Type | 2.59e-03 | 162 | 21 | 2 | 67b32c40cc180c5ebbfd901a417b5be469500110 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-03 | 162 | 21 | 2 | 71d7849108a1b59beff40e46000172c45a2f5439 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mast-Mast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.59e-03 | 162 | 21 | 2 | 30508c4007faa38b76246e3c6d7b3fde4492cc85 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.59e-03 | 162 | 21 | 2 | 33b73c6727b5c5ada2dddf304f56d84397725ca8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mast-Mast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.59e-03 | 162 | 21 | 2 | 44ef0932ee38964ff11edc2aa14698d9db3b2b6b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-03 | 162 | 21 | 2 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | Healthy_Control-Lymphoid-Plasma|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.62e-03 | 163 | 21 | 2 | 2913ccdd4613472cd82077d4993e1d9f8b223398 | |
| ToppCell | Healthy_Control-Lymphoid-Plasma-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.62e-03 | 163 | 21 | 2 | b589ff57d58dcb215ee3b5a10d81f43e5752a196 | |
| ToppCell | Control-MAIT|World / Disease group and Cell class | 2.62e-03 | 163 | 21 | 2 | 0ca4b835936b4f82217cbe57210c1dd90986c1d0 | |
| ToppCell | metastatic_Brain-Myeloid_cells-pDCs|metastatic_Brain / Location, Cell class and cell subclass | 2.65e-03 | 164 | 21 | 2 | 06db4cc064f0765c481ce880207823872c27bfa9 | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.65e-03 | 164 | 21 | 2 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.68e-03 | 165 | 21 | 2 | e2a70dd5870fe8708bf630ed3e6eb3f295df0cdf | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.68e-03 | 165 | 21 | 2 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.68e-03 | 165 | 21 | 2 | 37615622c736e43260c38016e7c9e565ac97a3e8 | |
| ToppCell | nucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.68e-03 | 165 | 21 | 2 | f3df74b5763130c71c0a482a3a23f6b22acc2892 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.71e-03 | 166 | 21 | 2 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-03 | 167 | 21 | 2 | a813b95c2fafb638b249bc4fa4f708c6f39ad444 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.78e-03 | 168 | 21 | 2 | 55f328353119cbdc521c782ebb8d163876f4186d | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.78e-03 | 168 | 21 | 2 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | Control-Mast_cells|Control / group, cell type (main and fine annotations) | 2.81e-03 | 169 | 21 | 2 | fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb | |
| ToppCell | severe-HSPC|World / disease stage, cell group and cell class | 2.81e-03 | 169 | 21 | 2 | b0421b73bfdc92f7a2762b4b670b9eae124aa702 | |
| ToppCell | E17.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.81e-03 | 169 | 21 | 2 | 56aa58636ec624819ca88c8c27a7493c3f8c49fc | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.81e-03 | 169 | 21 | 2 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.81e-03 | 169 | 21 | 2 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | Control-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations) | 2.84e-03 | 170 | 21 | 2 | c80f6d29096c372da95a8407f402349ff1bb7018 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.84e-03 | 170 | 21 | 2 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 2.84e-03 | 170 | 21 | 2 | 4dedf482cd4521b3f87d2b5ae80f7a3ea8686a15 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Eosinophil|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.88e-03 | 171 | 21 | 2 | fa6e856e62b82ec4972e0098e73f237cc611891f | |
| ToppCell | COVID-19-lung-RBC|lung / Disease (COVID-19 only), tissue and cell type | 2.88e-03 | 171 | 21 | 2 | 0e8d63c8fbccdda4f1ef00de00667a50464b104b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.88e-03 | 171 | 21 | 2 | 87d652afbb375f8ee50e5faecf6085630cd2163c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-03 | 172 | 21 | 2 | 3a37569a5902f3c65ff8d3912421309a8c82ee9b | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-03 | 172 | 21 | 2 | c74c1d47b133eb5d0f762a06e421252a76b4672b | |
| Disease | Vitiligo | 4.25e-05 | 101 | 20 | 3 | EFO_0004208 | |
| Disease | ethylmalonate measurement | 8.23e-05 | 20 | 20 | 2 | EFO_0020009 | |
| Disease | Parkinson's disease (biomarker_via_orthology) | 1.88e-04 | 30 | 20 | 2 | DOID:14330 (biomarker_via_orthology) | |
| Disease | Nonorganic psychosis | 9.96e-04 | 69 | 20 | 2 | C0349204 | |
| Disease | Psychotic Disorders | 2.12e-03 | 101 | 20 | 2 | C0033975 | |
| Disease | total blood protein measurement | 3.29e-03 | 449 | 20 | 3 | EFO_0004536 | |
| Disease | Bipolar Disorder | 3.90e-03 | 477 | 20 | 3 | C0005586 | |
| Disease | emphysema imaging measurement | 4.36e-03 | 146 | 20 | 2 | EFO_0007626 | |
| Disease | unipolar depression, bipolar disorder | 4.96e-03 | 156 | 20 | 2 | EFO_0003761, MONDO_0004985 | |
| Disease | electrocardiography | 5.23e-03 | 530 | 20 | 3 | EFO_0004327 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MKTLRNKMGKWCCHC | 91 | A5A3E0 | |
| IHLCMALASMAWLSG | 141 | Q8NGZ5 | |
| KLGMPMCLRLWQADC | 161 | Q9BYB4 | |
| GMMLLLCHWDGCLQF | 256 | Q9P1Z3 | |
| HGCLKWSMVCLLMNG | 116 | O75081 | |
| MKTLRNKMGKWCCHC | 91 | Q6S8J3 | |
| WQDIMLACMPGKKCA | 1466 | Q13936 | |
| CAKAVMWQKMLFGLC | 3661 | Q8TD57 | |
| ICKCGQAWGTMMVHK | 961 | Q9BYX4 | |
| MAKQWLLLMFHCVGS | 76 | Q5JSQ8 | |
| ISMMLLLCHWDGCLQ | 371 | Q9UL51 | |
| VMKPWHCLLMLLGSC | 136 | Q8NGR5 | |
| MKLCMGLACVLSLWN | 11 | C9JL84 | |
| PGMHKWKLEQCMVCT | 756 | O75592 | |
| GHWLLMDALAMGLCV | 161 | Q8TCT6 | |
| MGAVWTMKFSHCGRL | 511 | Q5JSH3 | |
| APLWMDQLCTGCMKT | 496 | Q9H857 | |
| MGAKSMRSWCLCQIC | 1 | Q658L1 | |
| DCGHGTVMLLAALWM | 411 | Q9HBG4 | |
| LAHKMGRWLCALLGM | 351 | Q05940 | |
| ADIMMGYHCWLCGKN | 836 | Q9UGR2 |